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NK cells can reduce anti-viral T cell immunity during
chronic viral infections, including infection with the
lymphocytic choriomeningitis virus (LCMV). How-
ever, regulating factors that maintain the equilibrium
between productive T cell and NK cell immunity are
poorly understood. Here, we show that a large viral
load resulted in inhibition of NK cell activation, which
correlated with increased expression of Qa-1b, a
ligand for inhibitory NK cell receptors. Qa-1bwaspre-
dominantly upregulated on B cells following LCMV
infection, and this upregulation was dependent on
type I interferons. Absence of Qa-1b resulted in
increased NK cell-mediated regulation of anti-viral T
cells following viral infection. Consequently, anti-viral
T cell immunity was reduced in Qa-1b- and NKG2A-
deficient mice, resulting in increased viral replication
and immunopathology. NK cell depletion restored
anti-viral immunity and virus control in the absence
of Qa-1b. Taken together, our findings indicate that
lymphocytes limit NK cell activity during viral infec-
tion in order to promote anti-viral T cell immunity.
INTRODUCTION
Innate lymphoid cells (ILCs) originate from a common lymphoid
progenitor, but do not express B or T cell receptors. Based on
their transcription factor and cytokine expression profiles, ILCs
can be classified into several subsets, including natural killer
(NK) cells, type 1 ILCs (ILC1s), ILC2s, ILC3s, and lymphoid
tissue-inducer cells (LTis) (Eberl et al., 2015a, 2015b). Similar
to cytotoxic CD8+ T cells, NK cells express Eomesodermin
and T-bet, which can induce perforin, granzyme, and IFN-g
expression (Gordon et al., 2012). In contrast, non-cytotoxic
ILC1s mainly express T-bet and produce IFN-g (Klose et al.,
2014). Transcription factor GATA-3 is required for ILC2 differen-
tiation (Hoyler et al., 2012). Activated ILC2s produce cytokines,
such as IL-4, IL-5, and IL-13 (Eberl et al., 2015a). Both ILC3s
and LTis require RORgt for their development and produce
similar cytokines, including IL-17, granulocyte-macrophage
colony-stimulating factor (GM-CSF), and IL-22 (Eberl et al.,
2015a, 2015b). The anti-viral function of NK cells is well docu-
mented. NK cells can control infection induced by viruses, such
as herpes simplex virus-1, influenza virus, ectromelia virus, and
murine cytomegalovirus, through IFN-g production or cytotox-
icity (Vivier et al., 2008). Emerging evidence suggests that other
ILC subsets also contribute to anti-viral defenses. IFN-g-pro-
ducing ILC1s are critical in controlling mouse hepatitis virus
(MHV) in Peyer’s patches and mesenteric lymph nodes (Gil-
Cruz et al., 2016). The organization of secondary lymphoid or-
gans after viral infection is mediated by LTis, hence improving
the efficacy of immune responses against re-infections (Scan-
della et al., 2008). Similarly, ILC2s are important for the main-
tenance of airway epithelial integrity during influenza virus
infection (Monticelli et al., 2011). Interestingly, a recent study
showed that ILC1s, ILC2s, and ILC3s are rapidly depleted
during acute HIV-1 infection (Kløverpris et al., 2016). Taken
together, the evidence suggests that ILCs are important and
are strictly regulated during viral infections.
Anti-viral T cell immunity is critical for overcoming viral infec-
tions as lack or dysfunction of T cells results in viral persis-
tence (Wherry, 2011). Previous studies have revealed that NK
cells can play a dual role during viral infections. Despite the
well-documented anti-viral functions of NK cells, they can
also target virus-specific T cells during viral infection and
contribute to the establishment of chronic viral infections
(Cook and Whitmire, 2013; Lang et al., 2012; Waggoner
et al., 2012). NK cells can be activated through type I interferon
(IFN-I) receptor signaling and exhibit perforin-mediated cyto-
toxicity (Biron et al., 2002; Ka¨gi et al., 1994). This NK cell-
dependent, perforin-mediated cytotoxicity inhibits anti-viral
T cell immunity and promotes chronic viral infection (Lang
et al., 2012; Waggoner et al., 2012). IFN-I also triggers the
expression of ligands for NK cell receptors on virus-specific
T cells, shifting the equilibrium toward NK cell inhibition
2528 Cell Reports 21, 2528–2540, November 28, 2017 ª 2017 The Authors.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
(Crouse et al., 2014; Xu et al., 2014). The expression of ligands
for the activating NK cell receptor NKp46 can be suppressed
by IFN-I (Crouse et al., 2014), and IFN-I induces the expression
of major histocompatibility complex (MHC) class I and class Ib
molecules, ligands for NK cell inhibitory receptors (Xu et al.,
2014). As a consequence, absence of IFN-I receptor (IFNAR)
signaling in T cells results in increased susceptibility of anti-
viral T cells toward NK cell-mediated attack (Crouse et al.,
2015a, 2015b). Consistently, deficiency of the transcription
factor Nlrc5 in T cells, which centrally controls expression of
MHC-I molecules, results in deletion of virus-specific T cells
by NK cells following viral infection (Ludigs et al., 2016).
T cells also express CD48, a ligand for the NK cell inhibitory
receptor and member of the signaling lymphocytic activation
molecule (SLAM) family receptor 2B4. SLAM-family-receptor-
deficient mice exhibit defective anti-viral T cell immunity,
mainly through effects mediated by 2B4 (Guo et al., 2016;
Waggoner et al., 2010). Despite the above mentioned studies,
whether NK cell-mediated regulation of anti-viral T cells is itself
modulated remains insufficiently studied.
The human MHC-Ib molecule HLA-E and the murine Qa-1b
both bind to NKG2 family members: NKG2A, NKG2C, and
NKG2E along with CD94 (Vance et al., 1999; Vance et al.,
1998; Zeng et al., 2012). The cytoplasmatic domain of NKG2A
contains an immunoreceptor tyrosine-based inhibitory motif
(ITIM) that suppresses NK cell activity following ligand binding
(Vance et al., 1998). In contrast, NKG2C-CD94 transmits
NK cell activation through binding of DAP12, which contains
an immunoreceptor tyrosine-based activating motif (ITAM)
(Lanier et al., 1998; Vance et al., 1999). The affinity for HLA-E
to the inhibitory CD94-NKG2A is higher than to the activating re-
ceptor CD94-NKG2C, suggesting that inhibitory signals could be
dominating (Vale´s-Go´mez et al., 1999). In mice, NKG2A is de-
tected on naive NK cells and activated T cells in contrast to
NKG2C or NKG2E when detected with an anti-NKG2A/C/E anti-
body (Rapaport et al., 2015). Qa-1b-deficient cells are targeted
by NK cells when transferred into wild-type (WT) animals
(Lu et al., 2007), while CD94-deficient mice exhibit similar NK
cell functions compared with WT animals (Orr et al., 2010). How-
ever, CD94-deficient mice are highly susceptible to ectromelia
virus. Using an overexpression model system, Fang et al.
(2011) demonstrated that NK cells can recognize the Qa-1b-ex-
pressing infected cells via the activating receptor NKG2E-CD94.
The inhibitory receptor CD94-NKG2A is expressed on activated
T cells, and deletion of NKG2A results in over-activation of
T cells, which can lead to apoptosis (Rapaport et al., 2015).
Despite these insights into the importance of Qa-1b and
NK cell interaction, the role of Qa-1b during viral infection
remains relatively unexplored.
In this study, we show that large viral doses increased
the expression of Qa-1b on B lymphocytes. Lack of Qa-1b
resulted in elevated NK cell-mediated regulation toward
T cells following lymphocytic choriomeningitis virus (LCMV)
infection. Consequently, Qa-1b- and NKG2A-deficient mice
exhibited reduced T cell immunity and defective viral control.
In addition, NK cell depletion could partially restore anti-viral
T cell responses and alleviate pathology in the absence
of Qa-1b.
RESULTS
NK Cell Activity Rapidly Decreases following Infection
with a Large Viral Load
HIV infection can result in a decrease of ILC subsets (Kløverpris
et al., 2016). To investigate whether LCMV infection changes ILC
populations, we characterized different ILC subsets early after
infection (Figure 1A). Although the presence of NK cells and
ILC subsets remained stable following infection with lower
doses, we observed a rapid decline in NK cells, ILC1s, ILC2s,
and LTis following infection with higher doses 2 days post-infec-
tion (Figure 1B). This observation was not restricted to spleen tis-
sue, as we also observed a decrease of ILC1s following infection
in liver tissue (Figure 1C), as well as a decrease of NK cells and
ILC1s in the blood (Figure 1D). As expected, LCMV titers were
significantly increased in the organs of animals infected with
higher LCMV doses (Figures S1A–S1C). Next, we transferred
negatively sorted CD8+ T cells from a mouse expressing a trans-
genic T cell receptor recognizing the LCMV peptide gp33 as a
transgene (P14) (Pircher et al., 1989) into WT mice followed by
low- and high-dose infection. Interestingly, we observed a
reduced presence of transferred T cells at day 1 and day 2
post-infection, and this correlated with reduced viability of the
T cells in high-dose-infected mice (Figure 1E). However, at
day 4 post-infection, the increased amount and viability of trans-
ferred T cells relative to the earlier time points prompted us to
speculate whether NK cell-mediated regulation of anti-viral
T cells is inhibited throughout the course of infection.
Qa-1b Triggers Inhibition of NK Cells and ILC1s
following LCMV Infection
To further investigate the underlying mechanism of NK cell-
mediated regulation of anti-viral T cells, we measured gene
expression of activating and inhibitory NK cell receptor ligands
in whole spleen tissue harvested 1 day after infection. In high-
dose-infected animals, genes encoding for NK cell receptor acti-
vating ligands were rather upregulated when compared with
low-dose-infected animals (Figure 2A). Notably, some ligands,
such as Cd23, showed lower expression levels when compared
with low-dose-infected animals (Figure 2A). However, when we
monitored gene expression of ligands for inhibitory receptors,
we found H2-t23 to be increased in high-dose-infected animals
(Figure 2A). Increased expression of Qa-1b overlapped with
B cell markers in spleen tissue sections of infected animals (Fig-
ure 2B). Using flow cytometry (FCM) analysis, increased Qa-1b
protein expression was detected in both B and T cells after
high-dose infection (Figure 2C). H2-t23 expression was also
significantly increased in sorted B cells from the high-dose-in-
fected animals (Figure S2A). However, H2-t23 gene and Qa-1b
protein expression in the spleen was similar in control and in-
fected mice following depletion of CD8+ or CD4+ T cells (Figures
S2B–S2D). On the other hand, B cell-deficient JhT/ or B and
T cell-deficient Rag1/mice had reduced levels of H2-t23 tran-
scripts and Qa-1b protein in spleen tissue after infection (Figures
2D–2F). Clodronate treatment did not alter Qa-1b expression on
an mRNA or protein level (Figures 2E and 2F). Collectively, these
data suggest that Qa-1b is predominantly expressed on B cells.
Notably, Qa-1b expression in spleen tissue was dependent on
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IFN-I, as lack of the receptor (IFNAR) abolished expression for
Qa-1b after LCMV infection (Figures S2E and S2F). Next, we
wondered whether Qa-1b expression on B cells might be an
important checkpoint of NK cell-mediated regulation of anti-viral
T cells. To test this, we infected control (H2-t23+/+ or H2-t23+/)
andH2-t23–/–mice (henceforth referred to asQa-1b–/–mice) with
LCMV. When we monitored NK cells and ILCs, we observed
similar decreases in NK cell and ILC numbers between control
and Qa-1b-deficient mice in spleen and liver tissue (Figures 3A
and 3B) 1 and 2 days post-infection with high-dose LCMV.
The expression of surface molecules between control and
Qa-1b/ mice was similar in NK cells and ILCs (Figure S3A).
Consistently, granzyme B and perforin expression was com-
parable in control and Qa-1b-deficient mice (Figure S3B). We
mainly detected positive staining with an anti-NKG2A/C/E
(clone: 20D5) antibody in NK cells and ILC1s (Figures 3C and
S3C), while cells from NKG2A-deficient mice failed to show a
positive signal (Figure S3D). These data suggest that NKG2A
is predominantly expressed on NK cells and ILC1s. Next,
we wondered whether NK-mediated regulation of anti-viral
T cells could be modulated by Qa-1b. To test this, we
transferred P14+CD8+ T cells into control and Qa-1b-deficient
mice. Interestingly, we observed reduced numbers of trans-





Figure 1. ILCs Rapidly Decrease following High-Dose LCMV Infection
(A) Representative FCMplots (n = 6) and gating strategy of spleen ILCs in C56BL/6mice are presented. Dead cells and Lin+ (CD3, CD5, CD8, CD19, Ly-6G, TCRb,
and FcεR1) cells were excluded, viable CD90.2+ CD45.2+ Lin cells were defined by conventional NK cells (NK1.1+ RORgT Eomes+), ILC1s (NK1.1+ RORgT
Eomes), ILC2s (NK1.1 RORgT CD11b GATA-3+), ILC3s (RORgT+ CD4), and LTis (RORgT+ CD4+).
(B–E) C56BL/6 mice were infected with low-dose (200 plaque-forming units [pfu]) or high-dose (23 106 pfu) LCMV WE. (B–D) ILC subsets in the spleen (B), liver
(C), and blood (D) tissue were determined at indicated time points (n = 6). (E) 106 negatively sorted CD8+ T cells from P14+ CD45.1+ animals were transferred into
CD45.2+ WT hosts followed by no infection or infection with low- or high-dose LCMV WE. Transferred P14+ cell number and viability were determined at the
indicated time points (n = 4). Error bars show SEM; *p < 0.05, **p < 0.01, ***p < 0.001; ns, not statistically significant between the indicated groups.
See also Figure S1.





Figure 2. Qa-1b Is Dominantly Expressed on B Cells following LCMV Infection
(A–C) C57BL/6 mice were infected with low- or high-dose LCMV WE and 1 day post-infection. (A) Gene expression levels for NK inhibitory or activating ligands
were determined in whole spleen tissue (n = 6). (B) Sections of snap frozen spleen tissue were analyzed for Qa-1b, CD19, CD8, and F4/80 expression (n = 6; scale
bar indicates 50 mm). (C) Qa-1b expression was determined on CD3–CD19+ B cells, CD3+CD8+ T cells, CD3+CD4+ T cells, and CD3–CD19–CD11b+ cells; 1 of 4
representative histograms is shown.
(D–F) WT, JhT/, Rag1/, clodronate-treated WT or Rag1/ animals were infected with high-dose LCMV WE, and 1 day after infection (D and E) H2-t23
expression levels in spleen tissue from WT or JhT–/– animals (D) or WT, Rag1/, clodronate treated WT or Rag1/ animals (E) were determined (n = 3–4).
(F) Sections of snap frozen spleen tissue were analyzed for Qa1, CD19, CD8, and F4/80 expression (n = 3–4; scale bar indicates 50 mm).
See also Figure S2.
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post-infection (Figure 3D). Furthermore, the transferred LCMV-
specific T cells exhibited reduced viability when compared with
control mice (Figure 3E). When we co-cultured concanavalin-
A-activated CD8+ T cells with NK cells, we observed that
Qa-1b/ CD8+ T cells were more susceptible toward NK cell-
mediated killing (Figure 3F). The Qa-1b binding peptide Qdm
increased Qa-1b expression on B cells (Figure 3G). Interestingly,
NK cell-mediated killing of T cells could be partially restored by
adding Qdm-stimulated B cells (Figure 3H). Taken together,
these data indicate that NK cells exhibit increased regulatory
functions against T cells in the absence of Qa-1b.
Absence ofQa-1bResults in Limited TCell Immunity and
Increased Pathology
NK cells can target anti-viral T cells and, as a consequence,
contribute to immunopathology and the establishment of chronic
viral infections (CookandWhitmire, 2013; Lang et al., 2012;Wagg-
oneretal., 2012).Therefore,wemonitoredanti-viral Tcell immunity
over time inQa-1b–/–andcontrolmice.Asexpected,Qa-1b–/–mice
exhibited reduced circulating LCMV-specific T cells following
infection with LCMV (Figure 4A). Additionally, LCMV-specific
T cells were reduced in spleen and liver tissue following LCMV




D E F G
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Figure 3. NK Cell-Mediated Regulation of T Cells Is Inhibited by Qa-1b-Expressing B Cells
(A–E) Control animals (Qa-1b+/+ or Qa-1b+/) and Qa-1b/mice were infected with high-dose LCMV WE, and the splenic ILC subsets (A) and liver ILC subsets
(B) were determined (n = 6). (C) NKG2A expression on NK and ILC1 cells were determined by staining with anti-NKG2A/C/E antibody (clone 20D5) (n = 4).
(D and E) 106 negatively sorted CD8+ T cells from P14+ CD45.1+ animals were transferred into CD45.2+ control or CD45.2+ Qa-1b/ hosts followed by infection
with high-dose LCMVWE. (D) The number of transferred P14+ cells was determined 2 days post-infection (n = 3–4). (E) P14+ viability wasmeasured by Annexin V
and 7AAD 2 days post-infection (n = 3–4).
(F) Negatively sorted CD8+ T cells from control animals and Qa-1b/mice were stimulated with Concanavalin A, and 24 hr later, 1,000 activated CD45.2+ CD8+
T cells were co-incubated with IL-2-derived CD45.1+ WT NK cells at the indicated effector-to-target ratio. Following a 4-hour incubation, the viability of activated
CD45.2+ CD8+ T cells was determined by 7AAD staining (n = 6).
(G) Positively sorted CD19+ B cells from control animals and Qa-1b/mice were incubated with 100 mg/mL Qdm peptide (AMAPRTLLL), and Qa-1b expression
on B cells was determined 24 hr later, 1 of 6 representative histograms is shown.
(H) A total of 1,000 Concanavalin-A-activated cells of negatively sorted CD8+ T cells from Qa-1b/ mice were co-incubated with IL-2-derived CD45.1+
WT NK cells at an effector-to-target ratio of 50:1 in the presence of 30,000 B cells from (G). Following a 4-hour incubation, the viability of activated CD45.2+ CD8+
T cells was determined by 7AAD staining (n = 6).
Error bars show SEM; *p < 0.05, **p < 0.01; ns, not statistically significant between the indicated groups. See also Figure S3.







Figure 4. Absence of Qa-1b Inhibits T Cell Immunity and Triggers LCMV-Induced Immunopathology
Control and Qa-1b/ mice were infected with high-dose LCMV WE.
(A) Gp33-specific tetramer was determined in the blood at the indicated time points after infection (n = 7–9).
(B) Gp33-specific tetramer in the spleen (left) and liver tissue (right) are shown 12 days post-infection.
(C) (Top) Representative histograms of day 12 splenic gp33-specific tetramer or naive splenic CD8+ T cells are shown. (Bottom) Mean fluorescence intensity (MFI)
of indicated molecules was quantified from day 12 splenic gp33-specific tetramer (n = 7–9).
(D) At day 12 post-infection, splenocytes (left panel) or liver cells (right panel) were re-stimulated with the LCMV-specific epitope gp33, followed by staining for
IFN-g (n = 7–9).
(E) Virus titers were determined from spleen, liver, lung, and kidney tissue 12 days post-infection (n = 7–9).
(legend continued on next page)
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such as dendritic cells, and therefore cause reduced T cell immu-
nity in the absence of Qa-1b (Crome et al., 2013). However, when
wemeasured innate IFN-I productionearly during infection,wedid
not observe any differences (Figure S4A). Furthermore, we did not
see differences between dendritic cell numbers in control and
Qa-1b-deficientmice (FigureS4B).Also, expressionofco-stimula-
tory molecules on dendritic cells (DCs) was increased following
LCMV infection in control and Qa-1b/ mice (Figure S4C).
Consistently, LCMV titers were comparable in tissue harvested
from control and Qa-1b-deficient mice at day 1 and 2 post-infec-
tion (Figures S4D and S4E). However, LCMV-specific T cells
exhibited higher expression of PD-1, TIM-3, and 2B4 in Qa-1b-
deficient mice compared with control animals, indicating an ex-
hausted state (Figure 4C) (Wherry, 2011). We observed no differ-
ence in the proportion of CD8+ T cells expressing IL7R and
CD62L between control and Qa-1b/ animals (Figure S4F), sug-
gesting Qa-1b did influence the function of anti-viral T cells.
Consistently, cytokine production of CD8+ T cells was reduced
following re-stimulation with LCMV-specific epitopes (Figure 4D).
We also observed significantly reduced LCMV-specific T cells in
the spleen of Qa-1b-deficient mice 4 and 8 days after infection
(Figures S5A–S5C), although expression of surface molecules
indicating an exhausted state was similar in control and Qa-1b-
deficient mice (Figure S5D). At day 8 post-infection, we observed
a significant increase in LCMV titers in the spleen (Figure S5E) and
higher viral loads in several organs harvested from Qa-1b–/– mice
12 days post-infection (Figure 4E). These findings were further
supported with an increased amount of LCMV-infected cells in
the liver tissue of Qa-1b–/– mice when compared with control ani-
mals (Figure 4F). Furthermore, increased activity of alanine amino-
transferase (ALT) was detectable in the blood stream, indicating
elevated liver damage in Qa-1b–/– mice (Figure 4G). In addition,
expression of a-smooth muscle actin (a-SMA) was higher in the
liver tissue of Qa-1b–/– mice than in the liver tissue of control ani-
mals following LCMV infection (Figure 4H). Since we observed
increased Qa-1b expression on B cells following LCMV infection,
we reconstituted lethally irradiated C57BL/6 animals with mixed
bone marrow from Qa-1b-deficient, B cell-deficient Jh/, B and
T cell-deficient Rag1/, and CD8+ T cell-deficient Cd8/ mice.
Weobservedsimilar anti-viral T cell immunity inmice reconstituted
with Qa-1b/: Cd8/ bone marrow when compared with
the corresponding controls (Figure S5F). However, reduced anti-
viral T cell immunity was observed in Qa-1b/:Rag1/ and
Qa-1b/:Jh/ hosts when compared with the corresponding
controls (Figures 4I and 4J). Consistently, increased viral titers
were detected in organs harvested from hosts receiving either
Qa-1b/:Rag1/ or Qa-1b/:Jh/ bone marrow when
compared with their corresponding controls (Figures 4K and 4L).
Thesefindings suggest thatQa-1bexpressiononBcells promotes
anti-viral T cell immunity.
Next, we wondered whether Qa-1b could affect the incidence
of chronic viral infection. We infected control and Qa-1b-defi-
cient mice with the chronic LCMV strain Docile and observed
similarly reduced T cell frequencies in Qa-1b/ mice when
compared with control animals (Figure 5A). This was associated
with increased PD-1 expression and reduced IL-7 receptor
(IL-7R) expression, indicating that LCMV-specific T cells were
in an exhausted state in the absence of Qa-1b (Figure 5B).
Consistently, cytokine production by CD8+ T cells was reduced
75 days after infection (Figure 5C). NK cells not only target anti-
viral CD8+ T cells, but also virus-specific CD4+ T cells during viral
infection (Waggoner et al., 2012). Interestingly, LCMV-specific
CD4+ T cells were also reduced in Qa-1b-deficient mice when
compared with control animals (Figures 5D and 5E). Hence, we
observed prolonged LCMV in the sera of Qa-1b/ mice when
compared with control animals (Figure 5F). LCMV was still
detectable in organs harvested from Qa-1b-deficient mice
75 days post-infection (Figures 5G and 5H). Taken together,
these data indicate that LCMV-specific T cell immunity is
reduced in Qa-1b-deficient mice, resulting in increased virus
replication and pathology, including chronic viral infection.
Next, we wondered whether the absence of the Qa-1b-binding
receptorNKG2Acould recapitulate theeffectsofQa-1bdeficiency
following LCMV infection. LCMV-specific T cells were also
reduced in NKG2A-deficient mice (Figure 6A). Moreover, cytokine
production was decreased in NKG2A-deficient Klrc1/ mice
when compared with WT controls (Figure 6B). LCMV titers were
increased following infection in the absence of NKG2A (Figures
6Cand6D).However, the effectsweobserved inNKG2A-deficient
micewerenotasprominentas those incurredbyQa-1bdeficiency.
ThismaybeexplainedbyaTcell-intrinsic roleofNKG2A (Rapaport
et al., 2015).Notably, LCMV-specificTcells showedpositivestain-
ing for anti-NKG2A/C/E (clone 20D5) in control and Qa-1b-defi-
cient animals following LCMV infection, while this staining was
absent in NKG2A-deficient mice, suggesting that LCMV-specific
T cells express NKG2A (Figures S5G and S5H). To investigate
the role of NKG2A on LCMV-specific T cells, we reconstituted
lethally irradiated C57BL/6 mice with mixed bone marrow from
Cd8/ and Klrc1/ mice. Following LCMV infection, we
observed increased T cell immunity at 12 days post-infection in
(F) Sections of snap frozen liver tissue from control and Qa-1b/ mice 12 days post-infection were analyzed for LCMV nucleoprotein expression by
immunohistochemistry; 1 representative image of n = 7–9 is shown (scale bar indicates 50 mm).
(G) ALT activity in the serum of control and Qa-1b/ mice was determined at 8 days post-infection (n = 7–9).
(H) Sections of snap frozen liver tissue from control and Qa-1b/ mice 12 days p.i were stained with a-smooth muscle actin (Alpha-SMA) antibodies
(1 representative image of n = 7–9 is shown, scale bar indicates 100 mm).
(I–L) Bone marrow cells from control or Qa-1b/mice were mixed at a 1:1 ratio with bone marrow cells from Rag1/ or JhT/mice and were transferred into
lethally irradiated WT mice. One month later, these mixed chimeric animals were infected with 2 3 105 LCMV WE, and splenocytes harvested 12 days after
infection. (I) Gp33-specific tetramer+CD8+ T cells in the spleen were determined inQa-1b/:Rag1/ andWT:Rag1/ reconstituted chimeras (left). IFN-g+CD8+
cells were measured in splenocytes from these animals following re-stimulation with the LCMV epitope gp33 (right). (J) Gp33-specific tetramer+CD8+ T cells in
the spleen were determined in Qa-1b/:Jh/ and WT:Jh/ reconstituted chimeras (left). IFN-g+CD8+ cells were measured in these samples following re-
stimulation with the LCMV epitope gp33 (right). (K and L) Virus titers were determined from spleen, liver, lung, and kidney tissue in (K) Qa-1b/:Rag1/ and
WT:Rag1/ reconstituted chimeras and (L) Qa-1b/:Jh/ and WT:Jh/ reconstituted chimeras (n = 8).
Error bars show SEM; *p < 0.05, **p < 0.01, ***p < 0.001; ns, not statistically significant between the indicated groups. See also Figures S4 and S5.
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hosts receiving the Cd8/:Klrc1/ bone marrow when
compared with hosts receiving the Cd8/:WT bonemarrow (Fig-
ure S5I). ALT activity was increased following infection of NKG2A-
deficient mice, indicating increased pathology during infection
(Figure 6E). In addition, NKG2A-deficient mice demonstrated an
increased expression of a-SMA, indicating a higher degree of
fibrosis following LCMV infection (Figure 6F). Taken together,
these data indicate that Qa-1b and its binding receptor NKG2A
promote anti-viral T cell immunity and alleviate virus-mediated
pathology following LCMV infection.
NK Cell Depletion Partially Restores Defective T Cell
Immunity and Prevents Pathology in Qa-1b-
Deficient Mice
Increased NK cell activation might limit CD8+ T cell immunity and
prolong viral replication and pathology. NK cells can be depleted
using an anti-NK1.1 antibody (clone: PK136) (Figure S6A). We
tested whether depletion of NK cells can improve T cell immunity
in Qa-1b-deficient mice. We transferred negatively sorted
LCMV-specific T cells into NK cell-depleted and NK cell-compe-
tent Qa1b/ and control mice. We observed that depletion of
NK cells could rescue the increased susceptibility of P14+
T cells in Qa-1b-deficient mice (Figure 7A). Furthermore, deple-
tion of NK cells resulted in the increased presence of LCMV-spe-
cific endogenous T cells in Qa-1b-deficient mice (Figure 7B).
Moreover, LCMV-specific T cell immunity was increased in
spleen tissue following NK cell depletion in Qa-1b-deficient ani-
mals (Figure 7C). Cytokine production after re-stimulation with
LCMV-specific epitopes was elevated in the absence of NK cells
in Qa-1b-deficient mice (Figure 7C). Consistent with previously
published data (Cook and Whitmire, 2013; Lang et al., 2012;






Figure 5. Absence of Qa-1b Leads to Prolonged LCMV Infection
Control and Qa-1b/ were infected with 2 3 104 pfu LCMV Docile.
(A) Gp33-specific tetramer was measured in the blood at the indicated time points after infection (n = 4–6).
(B) PD-1 (left) and IL-7R (right) expression on blood gp33-specific tetramer at the indicated time post-infection is shown (n = 4–6).
(C) At day 75 post-infection, splenocytes were re-stimulated with the LCMV epitope gp33, followed by measurement of IFN-g production (n = 4–6).
(D) Gp61-specifc CD4+ tetramer response in the blood at the indicated time points after infection was determined (n = 4–6).
(E) At day 75 post-infection, splenocytes were re-stimulated with the LCMV epitope gp61, followed by staining for IFN-g (n = 4–6).
(F) LCMV titers were measured in the blood at indicated time points following infection (n = 4–6).
(G) Virus titers were determined from spleen, liver, lung, kidney, spinal cord, and brain tissue 75 days post-infection (n = 4–6).
(H) Section of snap frozen liver tissue from control and Qa-1b/ mice 75 days post-infection were analyzed for LCMV nucleoprotein expression by immuno-
histochemistry; 1 of 4–6 representative images is shown (scale bar indicates 50 mm). Error bars show SEM; *p < 0.05, **p < 0.01, ***p < 0.001; ns, not statistically
significant between the indicated groups.
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cell-depleted control mice when compared with NK cell-compe-
tent control mice. However, we did not observe a complete
rescue in the spleens of Qa-1b-deficient mice by NK cell deple-
tion, indicating that there might be other NK cell-independent
factors contributing to diminished LCMV-specific T cell immunity
in the spleen tissue of Qa-1b-deficient animals (Figure 7C). How-
ever, surface molecule expression showed reduced expression
of PD-1, TIM-3, 2B4, and Lag-3 (Figures 7D and S6B). Further-
more, viral titers were reduced in Qa-1b-deficient animals
following treatment with anti-NK1.1 antibodies (Figure 7E). We
did not observe LCMV-infected cells in snap frozen liver tissue
in control or Qa-1b-deficient animals following treatment with
the NK cell-depleting antibody (Figure 7F). ALT activity was
reduced in the absence of NK cells in both control and Qa-1b-
deficient mice (Figure 7G). In addition, a-SMA staining was
reduced in anti-NK1.1-treated Qa-1b-deficient mice when
compared with NK cell-competent Qa-1b-deficient mice (Fig-
ure 7H). Taken together, these data indicate that NK cell deple-
tion can rescue defective T cell immunity in Qa-1b-deficient mice
and accordingly prevent pathology in these animals.
DISCUSSION
In this study, we identified a critical role for Qa-1b in inhibiting
NK cell activity following infection with LCMV. Lack of Qa-1b
resulted in increased NK cell-mediated regulation of T cell immu-
nity and consequently increased viral replication and pathology.
Depletion of NK cells partially restored T cell immunity and alle-
viated pathology in this setting.
Qa-1b can bind to the inhibitory NK cell receptor NKG2A-
CD94 and to the activating NK cell receptor NKG2C-CD94
(Lanier et al., 1998; Vance et al., 1998). However, only NKG2A
appears to be expressed in murine NK cells and activated
T cells in contrast to NKG2C or NKG2E (Rapaport et al., 2015).
Interestingly, deletion of CD94 results in increased susceptibility
to ectromelia virus infections (Fang et al., 2011). NKG2A-defi-
cient mice are susceptible to ectromelia virus infections, sug-
gesting that the effects of CD94 deficiency are transmitted by
NKG2A-CD94 (Rapaport et al., 2015). In our setting, hyperactive
NK cells targeted virus-specific T cells following infection, which
impaired anti-viral immunity. Notably, Qa-1b was mainly ex-
pressed on B cells after infection, suggesting that B cells govern
the equilibrium between regulatory NK cell function and T cell
activation (Rapaport et al., 2015). Although NK cell depletion
could only partially restore anti-viral T cell responses during
LCMV infection, NK cell depletion rescued virus-mediated
pathology, which suggests that NK cells are a critical component
in the effects observed with Qa-1b deficiency.
In humans, the role of NK cells during chronic viral infection




Figure 6. NKG2A Promotes Anti-viral T Cell Immunity Resulting in Limited Pathology during LCMV Infection
Control (C57BL/6) and Klrc1/ mice were infected with high-dose LCMV WE.
(A) Splenic gp33-specific tetramer was measured 12 days post-infection (n = 9–11).
(B) At day 12 post-infection, splenocytes were re-stimulated with the LCMV-specific epitope gp33, followed by determination of IFN-g production (n = 9–11).
(C) Virus titers were determined from spleen, liver, lung, and kidney tissue 12 days post-infection (n = 9–11).
(D) Sections of snap frozen liver tissue from control and Klrc1/ mice 12 days post-infection were analyzed for LCMV nucleoprotein expression assessed by
immunohistochemistry; 1 representative image of n = 7–8 is shown (scale bar indicates 50 mm).
(E) ALT activity in the serum of control and Klrc1/ mice was measured 8 days post-infection (n = 11–12).
(F) Sections of snap frozen liver tissue from control andKlrc1/mice 12 days post-infection were stained with a-smoothmuscle actin (Alpha-SMA) antibody; 1 of
7–8 representative images is shown (scale bar indicates 100 mm). Error bars show SEM; *p < 0.05; ns, not statistically significant between the indicated groups.
See also Figure S5.





Figure 7. NK Cell Depletion Partially Restores Defective T Cell Immunity and Prevents Pathology in Qa-1b-Deficient Mice
(A) A total of 106 negatively sorted CD8+ T cells from P14+ CD45.1+ animals were transferred into NK cell-depleted or non-depleted CD45.2+ control or CD45.2+
Qa-1b/ hosts followed by infection with high-dose LCMVWE. The number of transferred P14+ cells was determined 2 days post-infection (n = 4–5, left). P14+
cell viability was determined by Annexin V and 7AAD 2 days post-infection (n = 4–5, right).
(B–H) NK cell-depleted and non-depleted control and Qa-1b/ mice were infected with high-dose LCMV WE.
(B) Gp33-specific tetramer was measured in the blood at the indicated time points after infection (n = 8–10; *p < 0.05, **p < 0.01, ***p < 0.001 between the control
and Qa-1b/ group; #p < 0.05, ###p < 0.001 between Qa-1b/ and NK cell-depleted Qa-1b/ animals).
(C) Twelve days post-infection, gp33-specific CD8+ T cells in the spleenwere determined (left). IFN-g productionwasmeasured in response to incubation with the
LCMV epitope gp33 (n = 8–10, right).
(D) Representative histograms of the indicated surface molecules on splenic gp33-specific CD8+ T cells are shown (n = 8–10).
(E) Virus titers were determined from spleen, liver, lung, and kidney tissue 12 days post-infection (n = 8–10).
(F) Sections of snap frozen liver tissue from NK cell-depleted or non-depleted control or Qa-1b/ mice 12 days post-infection were analyzed for LCMV
nucleoprotein expression by immunohistochemistry; 1 representative image of n = 8–10 is shown (scale bar indicates 50 mm).
(legend continued on next page)
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understood. Human chronic viral infections with hepatitis B or
hepatitis C virus lead to induced cytotoxicity of NK cells (Ahlen-
stiel et al., 2010; Oliviero et al., 2009; Rehermann, 2013). This
NK cell activation may be triggered by IFN-I (Ahlenstiel et al.,
2010), which can be produced by plasmacytoid DCs (pDCs) or
Kupffer cells after sensing hepatitis C virus (HCV) RNA (Lau
et al., 2013; Takahashi et al., 2010). During infection with HCV,
expression of NK cell inhibitory receptors and their correspond-
ing ligands correlates with the elimination of HCV (Khakoo et al.,
2004; Knapp et al., 2010; Paladino et al., 2007). However, treat-
ment with IFN-I results in immediate increases in ALT levels
caused by NK cell-mediated virus elimination, suggesting a pro-
tective role of NK cells during viral-induced hepatitis (Ahlenstiel
et al., 2011). Furthermore, the reaction of NK cells to interferon
treatment can serve as an indicator of effectiveness in patients
suffering from HCV infection (Oliviero et al., 2013) and as a pre-
dictor of treatment outcome (He et al., 2006; Sarasin-Filipowicz
et al., 2008). During HCV and HBV infection, the activating
NK cell receptors NKp30, NKp46, NKG2C, NKG2D, and
CD122 and the inhibitory receptor NKG2A are upregulated
(Rehermann, 2013). Interestingly, the HCV peptide aa35–44 sta-
bilizes the NKG2A binding HLA-E and consequently increases its
expression and triggers inhibition of NK cells (Nattermann et al.,
2005). There are two polymorphisms of HLA-E, which only differ
in one amino acid, an arginine (HLA-E*0101, HLA-ER) or a glycine
(HLA-E*0103, HLA-EG) in position 107 with increased surface
expression of HLA-ER polymorphism (Strong et al., 2003). Inter-
estingly, homozygous expression of HLA-ER correlates with
clearance of HCV genotype 2 and 3 (Schulte et al., 2009). As sug-
gested by our data, increased HLA-E expression might reduce
NK cell activity and promote virus-specific T cell immunity.
Taken together, this study identifies Qa-1b to be predomi-
nantly upregulated on B cells during infection with LCMV.
Furthermore, lack of Qa-1b resulted in NK cell-mediated dimin-
ished anti-viral T cell immunity and increased pathology, which
was partially rescued with NK cell depletion.
EXPERIMENTAL PROCEDURES
Mice
Qa-1b/, Klrc1/, Rag1/, JhT/, Ifnar1/, and CD45.1+ P14+ mice were
bred in a C57BL/6 background and maintained under specific pathogen-free
conditions. Experiments were performed under the authorization of Lande-
samt f€ur Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen (LANUV)
in accordance with German law for animal protection. For Qa-1b/-related
experiments, littermate controls (Qa-1b+/+ or Qa-1b+/) were used. For the
rest of the animals, WT (C57BL/6) mice were used as controls. For chimera
experiments, WT mice were irradiated with 10.5Gy. One day later, mice
were reconstituted bone marrow cells from indicated donors.
Viruses
LCMV strain WE was originally obtained from F. Lahmann-Grube (Heinrich
Pette Institute). LCMV strain Docile was originally obtained from Dr. C.J.
Pfau (Troy, NY). Viruses were propagated in L929 cells as previously described
(Welsh and Seedhom, 2008). Virus titers weremeasuredwith a plaque-forming
assay as previously described (Battegay et al., 1991).
Cell Depletion
NK cells were depleted with intravenous (i.v.) injections of anti-NK1.1
(clone PK136) as previously described (Xu et al., 2014). CD8 and CD4 cell
were depleted with i.v. injections of anti-CD8 (clone YTS169.4) or anti-CD4
(clone YTS 191) as previously described (Lang et al., 2008; Pellegrini et al.,
2011). For depletion of macrophages, mice were treated with clodronate
liposomes. Control mice were treated with empty control liposomes (Lang
et al., 2010).
Histology
Histological analysis on snap frozen tissue was performed as previously
described (Recher et al., 2007) by using CD8, F4/80, CD19 (eBioscience),
alpha smooth muscle actin (Abcam), Qa-1b (BD Biosciences), and self-
made anti-LCMV monoclonal antibody (Clone: VL4).
ELISA
IFN-a ELISA kit was purchased from PBL Biosciences. All experiments were
performed according to the manufacturers’ instructions.
Flow Cytometry Analysis
Experiments were performed using a FACS Fortessa and analyzed
with FlowJo software. For ILC staining, single suspended cells were
prepared and washed twice with PBS, incubated with fixable live/dead
dye (eBioscience) and Fc block (eBioscience), and then stained with
NKG2A/C/E(clone 20D5), CD3, CD5, CD19, Ly-6G, CD8, FceR1, TCRb,
NK1.1, CD11b, CD45.2, CD90.2, CD4, RORgT, GATA-3, and EOMES, along
with beads for cell counting (BD). Intracellular cytokine staining of ILCs was
performed with a Foxp3 mouse regulatory T cell (Treg) staining buffer kit
(eBioscience). Tetramer and intracellular cytokine staining were performed
as described previously (Xu et al., 2014). For tetramer staining, single
suspended cells were incubated with tetramer-gp33 (CD8) for 15 min or
incubated with tetramer-gp61 (CD4) for 30min at 37C. After incubation,
anti-CD8 (eBioscience) or anti-CD4 (eBioscience) surface antibodies were
added for 30 min at 4C. For intracellular cytokine re-stimulation, single
suspended cells were stimulated with LCMV-specific peptide gp33 and
gp61 for 1 hr, and Bredeldin A (eBiocience) was added for another 5-hr
incubation at 37C. A FACS Aria III was used for Flow Cytometry based
cell sorting experiments.
NK Cell Purification and Culture
Single-cell suspended splenocytes were enriched following the manufac-
turer’s instructions with the DX5 MACS kit (Miltenyi Biotec). Positively
sorted NK cells were stimulated with 1,000 U/mL IL-2 (Miltenyi Biotec)
for 4 days.
B Cell Purification
Single-cell suspended splenocytes were enriched following the manufac-
turer’s instructions with the CD19 MACS kit (Miltenyi Biotec). Positively sorted
CD19+ B cells were incubated with 100mg/mL Qdm peptide (AMAPRTLLL)
for 24 hr.
In Vitro Flow-Cytometry-Based NK Killing Assay
Negatively sorted CD8+ T cells were stimulated with 5 mg/mL Concanavalin
A for 24 hr, and dead cells were removed by gradient centrifugation (Ficoll-
Paque 1.084, GE Healthcare). Live activated CD8+ T cells were co-incubated
with IL-2-derived NK cells and B cells at indicated effector-to-target ratio in the
(G) ALT activity in the serum of NK cell-depleted or non-depleted control orQa-1b/mice was determined at indicated time points (n = 8–10; *p < 0.05, **p < 0.01
between the control and Qa-1b/ group; ###p < 0.001 between Qa-1b/ and NK cell-depleted Qa-1b/ animals).
(H) Sections of snap frozen liver tissue were stained with a-smooth muscle actin (Alpha-SMA) antibody; 1 representative image of n = 8–10 is shown
(scale bar indicates 100 mm). Error bars show SEM; *p < 0.05, **p < 0.01, ***p < 0.001; ns, not statistically significant between the indicated groups.
See also Figure S6.
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presence of 2 U/mL IL-2 for 4 hr. DeadCD8+ T cells were identified by 7-amino-
actinomycin D (7AAD) staining. NK-specific killing was calculated by (% live
T cells (without co-incubation with NK cells) – % live T cells (co-incubation with NK cells))/
(% live T cells (without co-incubation with NK cells)).
RNA Purification and RT-PCR
RNA purification was performed according to the manufacturer’s instructions
(QIAGEN). Gene expression of H2-T23, H2-K1, Clec2d, Cd48, Cdh1, Col17a1,
Cd70, Pvr, Icam1, Pvrl2, Slamf7, Ulbp1, Icam5, Rae1, Icam2, Vcam1, Cadm1,
CD99, Cd23, and Gapdh were performed using a kit from Bio-Rad. For anal-
ysis, the expression levels of all genes were normalized to Gapdh (DCt [cycle
threshold]). Then gene expression values were calculated based on the
DDCt method relative to naive WT controls. Relative quantities (RQs) were
determined using the equation: RQ = 2^ – DDCt.
Statistical Analysis
Data are expressed as mean ± SEM. For analysis of statistical significance
between two groups a Student’s t test was used. For the analysis of multiple
time points experiment, two-way ANOVA with an additional Bonferroni post-
test was used; p < 0.05 was considered as statistically significant.
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